The 20 Best Spastic Paraplegia Type 7 Doctors Near Me in Maryland, US

Dr. Ricardo Roda earned a combined MD/PhD degree from University of Rochester and completed an adult neurology residency, followed by a clinical neuromuscular fellowship at Johns Hopkins University School of Medicine. During residency, Dr. Roda developed a special interest in both auto-immune disorders and genetic disorders. Following residency, he spent three years in neurogenetics branch of National Institute of Neurological Disorders and Stroke (NINDS) working with Dr. Craig Blackstone, focusing on the use of the newer DNA sequencing techniques in genetic diagnosis, and in establishing genotype/phenotype correlations neuromuscular disorders. His current clinical interests include developing testing strategies for undiagnosed genetic disorders and myasthenia gravis. Dr. Roda is rated as a Distinguished provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Myasthenia Gravis, Spastic Paraplegia Type 2, and Hereditary Spastic Paraparesis. Dr. Roda is board certified in American Board Of Psychiatry And Neurology.

Neurologist Payam Mohassel specializes in myopathies, muscular dystrophies, and other hereditary neuromuscular disorders and is the co-director of the Johns Hopkins Myositis Center. Dr. Mohassel obtained his medical degree from the Johns Hopkins University School of Medicine, where he remained for a medical internship, residency training in neurology, and clinical fellowship training in neuromuscular medicine. He then joined the National Institute of Neurological Disorders and Stroke Neurogenetics branch as a clinical research fellow. Dr. Mohassel’s research focuses on translational studies on neuromuscular disorders, and it spans gene discovery efforts, mechanistic studies to identify therapeutic targets, and early phase interventional clinical trials. Dr. Mohassel is rated as an Advanced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Hereditary Sensory Neuropathy Type 1 (HSN1), and Hajdu-Cheney Syndrome. Dr. Mohassel is board certified in American Board Of Psychiatry And Neurology.

Sinnarajah Raguraj is a primary care provider, practicing in Internal Medicine in Bel Air, Maryland. Dr. Raguraj is rated as an Advanced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Anemia, Familial Combined Hyperlipidemia, Xanthoma, and Hypertensive Heart Disease. Dr. Raguraj is currently accepting new patients.

Travis Edmiston, M.D., is a rehabilitation physician specializing in treating people with spinal cord injuries and dysfunction at the International Center for Spinal Cord Injury at Kennedy Krieger Institute. He uses modern treatment approaches that support all aspects of recovery after a spinal cord injury. Learn about scheduling an appointment with the Center for Spinal Cord Injury. Dr. Edmiston obtained his medical degree from Oregon Health & Science University. He completed his residency in physical medicine and rehabilitation at the Johns Hopkins University School of Medicine, followed by a fellowship in spinal cord injury medicine at Kennedy Krieger Institute and Johns Hopkins. Before joining Johns Hopkins and Kennedy Krieger, Dr. Edmiston worked as an attending physician for the inpatient acute spinal cord injury unit at the Los Angeles County Department of Health Services Rancho Los Amigos National Rehabilitation Center. Dr. Edmiston’s research interests focus on improving recovery and independence for people with spinal cord injury. He has been involved with several quality improvement efforts focused on opioid safety, improving rates of discharge to the community after injury and integrating the multispecialty rehabilitation team earlier into a patient’s hospital care. Dr. Edmiston is rated as an Advanced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Neurogenic Bowel, Paraplegia, Spasticity, and Spastic Paraplegia Type 2.

Mark Klaiman is a Physiatrist practicing medicine in Bethesda, Maryland. Dr. Klaiman is rated as an Advanced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Sciatica, Adolescent Idiopathic Scoliosis, Scoliosis, and Spastic Paraplegia Type 5A.

Dr. Hilary E. Gwynn is an instructor on the medical staff at Kennedy Krieger Institute in the Division of Neurology and Developmental Medicine. She teaches medical trainees and provides patient care at the Center for Development and Learning and on the Pediatric Rehabilitation Unit. She is also the site coordinator for the Johns Hopkins pediatric resident developmental disabilities rotation at the Kennedy Krieger Institute. Dr. Gwynn earned her medical degree at the University of Maryland School of Medicine in Baltimore, Maryland in 2000 and completed her pediatrics residency there in 2003. She subsequently joined the Kennedy Krieger Institute in 2003 to attend the fellowship in neurodevelopmental disabilities through the Kennedy Krieger Institute and Johns Hopkins University School of Medicine. Since graduation from the fellowship program in 2007, she has been an active member of the medical staff at Kennedy Krieger Institute. She teaches medical trainees and provides patient care at the Center for Development and Learning and on the Pediatric Rehabilitation Unit. She is also a member of the clinical staff of the Department of Pediatrics at Johns Hopkins School of Medicine. Contact for Research Inquiries 801 N. Broadway Baltimore, MD 21205 Phone: (443) 923-3246 Research Summary Dr. Gwynn's clinical and research interests include diagnosis and treatment of the child with developmental disability. She is also investigating medical training methodology as it applies to resident and fellow training in the practice of developmental medicine and child neurology. Dr. Gwynn is rated as an Advanced provider by MediFind in the treatment of Spastic Paraplegia Type 7. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Focal Dystonia, Spastic Diplegia Infantile Type, and Moebius Syndrome.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis. Dr. Banwell is board certified in Royal College Of Physicians And Surgeons Of Canada.

Liana Rosenthal, M.D. is an Assistant Professor in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Rosenthal completed medical school at Johns Hopkins with an internship at Johns Hopkins Bayview Medical Center. She completed her neurology residency and movement disorder fellowship at The Johns Hopkins Hospital. Dr. Rosenthal is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Movement Disorders, Parkinson's Disease, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia. Dr. Rosenthal is board certified in American Board Of Psychiatry And Neurology.

Dr. Michael Polydefkis focuses on neuromuscular diseases, particularly peripheral nerve diseases. He has a special interest in diabetic and HIV-associated peripheral neuropathy. His expertise includes nerve conduction studies, electromyography and nerve, skin and muscle biopsy reading. Dr. Michael Polydefkis received his medical degree from The Johns Hopkins University School of Medicine. He then became a Howard Hughes Medical Institute research fellow before returning to Johns Hopkins to complete an internship and residency in internal medicine, residency in neurology and a fellowship in neuromuscular diseases. Dr. Polydefkis is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Transthyretin Amyloidosis, Familial Transthyretin Amyloidosis, Primary Amyloidosis, and Peripheral Neuropathy.

Dr. R. Samuel Mayer is an associate professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine. His clinical interests include complications of critical illness, spine disorders, pain management, disorders of muscle tone and cancer rehabilitation. Dr. Mayer serves as the director of cancer rehabilitation, director of undergraduate medical education and residency program director for the Department of Physical Medicine and Rehabilitation. He graduated from the honors program in medical education at Northwestern University School of Medicine and completed his residency in physical medicine and rehabilitation at Rush Medical College. He was chair of the Committee on Medical Education for the American Medical Student Association while he was a medical student. After completing his residency, he remained on faculty at Rush Medical College, eventually becoming the residency program director and acting chair of the Department of Physical Medicine and Rehabilitation. He joined the Department of Physical Medicine and Rehabilitation at Johns Hopkins in 2001. Dr. Mayer serves as director of the Medical Student Summer Clinical Experience in Physical Medicine and Rehabilitation for the Association of Academic Physiatrists. He is Editor in Chief of Knowledge NOW, the American Academy of Physical Medicine and Rehabilitation's online encyclopedia of the field. In 2014, he was named Distinguished Clinician by the American Academy of Physical Medicine and Rehabilitation. Dr. Mayer is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Pediatric Low-Grade Glioma (pLGG), Hemiplegia, Miller-Fisher Syndrome, and Guillain-Barre Syndrome. Dr. Mayer is board certified in American Board Of Physical Medicine And Rehabilitation.

Dr. Becker is a neurologist who earned his Medical Degree from Ruprecht Karls University in Heidelberg, Germany in 2001. From 2001 to 2003, he was a Research Assistant in Neuroscience investigating the role of embryonic stem cells in spinal cord injury repair at Washington University School of Medicine in St. Louis, Missouri. At Vanderbilt University Medical Center in Nashville, Tennessee, he completed his residency in Internal Medicine in 2004 and his residency in Neurology in 2007. From there, he completed a year-long fellowship in Spinal Cord Injury Medicine at the Johns Hopkins School of Medicine in Baltimore, MD. Dr. Becker is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Paraplegia, Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Cerebellar Multiple System Atrophy. Dr. Becker is board certified in American Board Of Psychiatry And Neurology.

Dr. Tracy Friedlander is a clinical associate specializing in neurological rehabilitation at the Johns Hopkins Department of Physical Medicine and Rehabilitation. Her focus is on helping patients manage spasticity (a muscle control disorder) through a variety of treatment approaches. Dr. Friedlander graduated from Emory University in Atlanta, GA, and earned her medical degree at the University of Maryland School of Medicine. She interned at Mercy Medical Center and completed her residence in physical medicine and rehabilitation at Sinai Hospital of Baltimore. Videos Dr. Tracy FriedlanderNeurological Rehabilitation Selected Publications Henrikson CA , Howell EE , Bush DE , Miles JS , Meininger GR , Friedlander T , Bushnell AC , Chandra-Strobos N. Prognostic usefulness of marginal troponin T elevation. The American Journal of Cardiology. 2004 Feb; 93(3): 275-279. Henrikson CA , Howell EE , Bush DE , Miles JS, Meininger GR , Friedlander T , Bushnell AC , Chandra-Strobos N. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Annals of Internal Medicine. 2003 Dec; 139(12): 979-986 Courses & Syllabi Inpatient Rehabilitation of Spinal Cord Injury, Johns Hopkins University. Dr. Friedlander is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Hemiplegia, Miller-Fisher Syndrome, Guillain-Barre Syndrome, and Spasticity. Dr. Friedlander is board certified in American Board Of Physical Medicine And Rehabilitation.

Dr. Elrick specializes in the care of children with neuromuscular disorders, and EMG studies in children and adults. He has special interests in genetic neuromuscular and neurodegenerative disorders and Acute Flaccid Myelitis. Dr. Elrick earned his M.D. and Ph.D. in Neuroscience at the University of Michigan Medical School, studying inherited neurodegenerative disorders of childhood. He completed residency training in Pediatrics and Child Neurology, followed by a fellowship in Neuromuscular Medicine and Johns Hopkins before joining the faculty in 2019. Dr. Elrick's laboratory research interest is in understanding mechanisms of neurodegenerative disease, especially those affecting motor neurons. He studies disorders caused by genetic mutations in the nuclear pore complex, the main pathway for transport of material in and out of the nucleus of the cell, including Triple A Syndrome. He also participates in clinical research on Acute Flaccid Myelitis (AFM), aimed at understanding susceptibility to AFM in children, and defining clinical and EMG characteristics of illness and recovery in AFM. Dr. Elrick is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cramp-Fasciculation Syndrome, Acute Flaccid Myelitis (AFM), Dysferlinopathy, and Duchenne Muscular Dystrophy. Dr. Elrick is board certified in American Board Of Psychiatry And Neurology.

Sarah Korth, M.D. is an instructor at the Johns Hopkins Department of Physical Medicine and Rehabilitation. She serves as an attending physician at The Johns Hopkins Hospital and the Kennedy Krieger Institute. Dr. Korth’s interests include neuroplasticity of the developing brain, maximizing mobility, spasticity management, neurogenic bowel and bladder management, and a whole-person approach to management of children and adults with congenital conditions, including cerebral palsy and spina bifida. Dr. Korth’s rehabilitation-focused care aims to help people with congenital and acquired disabilities reach their maximum function. Dr. Korth also has an ongoing interest in methods of decreasing health disparities in developing countries. While in medical school, Dr. Korth initiated and developed a sustainable-changes health program called The Paraiso Project in rural Dominican Republic that she actively continues to direct. Dr. Korth is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Myelomeningocele, Hydrocele, Cerebral Palsy, and Neurogenic Bowel. Dr. Korth is board certified in American Board Of Physical Medicine And Rehabilitation and American Board Of Pediatrics.

Dr. Barañano earned her M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine, where she also completed residencies in pediatrics and neurology, along with a fellowship in neurogenetics at the Kennedy Krieger Institute. Dr. Barañano is an Associate Professor of Clinical Neurology. She specializes in the diagnosis and management of rare neurogenetic disorders. She has a particular interest in the genetic control and function of the cerebellum and expertise in childhood-onset and inherited ataxias. She is a member of the multidisciplinary Fetal Management group and is available for prenatal consultations. Dr. Barañano's research includes collaborative efforts with the Johns Hopkins Department of Genetic Medicine and the Division of Neurogenetics at the Kennedy Krieger Institute. Dr. Baranano is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Hypotonia, Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant, Focal or Multifocal Malformations in Neuronal Migration, and Spinocerebellar Ataxia Type 3. Dr. Baranano is board certified in American Board Of Psychiatry And Neurology.

Neurologist Ashley Paul specializes in movement disorders and also serves as a clinician educator. Dr. Paul has expertise in Parkinson's Disease, atypical parkinsonism, tremors, chorea, dystonia, ataxia, restless leg syndrome, rapid eye movement sleep behavioral disorders, periodic limb movement of sleep and deep brain stimulation. She offers botulinum toxin injections for the treatment of dystonia. Dr. Paul is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. Her clinical expertise encompasses Hereditary Ataxia, Corticobasal Degeneration, Parkinson's Disease, and Movement Disorders. Dr. Paul is board certified in American Board Of Psychiatry And Neurology.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Supranuclear Ophthalmoplegia, and Movement Disorders.

Dr. Habela completed a Medical Scientist Training Program at the University of Alabama, Birmingham. She received her PhD in Neurobiology in 2008 and her MD in 2010. After medical school, she specialized in child neurology, and completed 2 years of pediatrics residency and 3 years of child neurology residency at the Johns Hopkins Hospital in 2015. She then completed another 2 years of training specifically focused on the diagnosis, characterization and medical and surgical management of patients with epilepsy during an Epilepsy Fellowship at Johns Hopkins. Dr. Habela’s clinic specializes in pediatric neurology and epilepsy. Her clinical focus in on the care of patients with severe epilepsy with or without other neurodevelopmental disorders that have not been easily controlled with medications. She is also focused on the genetic causes of epilepsy and other neurodevelopmental disabilities with the hope that increasing our understanding of the genetic causes of epilepsy and neurodevelopmental disabilities will improve treatment. Dr. Habela’s basic science research is focused on the genetic mechanisms regulating appropriate proliferation, migration and integration of neurons and glial cells in both the prenatal and postnatal developing brain and how aberrations in these processes result in neurodevelopmental disabilities. Her hypothesis is that deregulation of pre and postnatal neurogenesis and synaptogenesis contributes to the behavioral phenotypes observed in many forms of intellectual disability, epilepsy and autism. Her research applies what we know from human genetic studies to basic science studies examining how specific genetic changes alter neurogenesis, synaptogenesis and overall excitation / inhibition balance in laboratory model systems. Her goal is to provide a better understanding of the molecular mechanisms of these processes and, in turn, possibly identify specific targets for disease modifying treatments for epilepsy. Contact for Research Inquiries 600 N. Wolfe Street Meyer 2-147 Baltimore, MD 21287 Phone: (410) 955-9100. Dr. Habela is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Epilepsy, and Endovascular Embolization. Dr. Habela is board certified in American Board Of Psychiatry And Neurology.

Nicholas Maragakis treats patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). This care is coordinated with the Johns Hopkins Center for ALS Specialty Care, a multidisciplinary clinic with expertise in treating patients with ALS and providing support to their caregivers. He serves as medical director of the ALS Clinical Trials Unit, an extension of the multidisciplinary clinic that seeks to facilitate opportunities for patients with ALS to participate in clinical trials that could advance the treatment of this disease. Dr. Maragakis is interested in the basic science of understanding neurodegenerative diseases, as well as the translational potential of therapeutic compounds developed in the laboratory. His fundamental research interest is in using stem cells — more specifically, stem cell-derived motor neurons and glia — for understanding the development and propagation of ALS. His laboratory has been involved in creating and characterizing lines of stem cells from patients with ALS using induced pluripotent stem cell (iPSC) methodologies. The laboratory has a large library of iPSCs from patients with familial ALS and from patients with sporadic ALS. The utilization of this library of iPSCs has facilitated the development of a spinal cord-specific iPSC-astrocyte/motor neuron co-culture system, which has been leveraged for the development of assays that can be used for both the basic understanding of ALS astrocyte and motor neuron biology as well as, eventually, drug screening for ALS therapeutics. His laboratory has taken its long-standing interests in astrocyte biology, as it relates to ALS, to develop a program that investigates astrocyte-specific mechanisms as contributors to the progression (both temporally and anatomically) of disease in ALS. In this vein, there is an interest in astrocytic glutamate transporters and, more recently, astrocyte hemichannels and gap junctions. Dr. Maragakis is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, 15q11.2 Microdeletion, and Spinal Muscular Atrophy (SMA).

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Experienced provider by MediFind in the treatment of Spastic Paraplegia Type 7. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy. Dr. Hoke is board certified in American Board Of Psychiatry And Neurology.